{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T18:40:05Z","timestamp":1750444805099,"version":"3.41.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271958"],"award-info":[{"award-number":["82271958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012149","2024A1515011968"],"award-info":[{"award-number":["2024A1515012149","2024A1515011968"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04764-0","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T01:22:11Z","timestamp":1734571331000},"page":"3187-3198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic syndromes associated with pancreatic neuroendocrine neoplasms and imaging diagnostic strategies"],"prefix":"10.1007","volume":"50","author":[{"given":"Jiawei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siya","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Ting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanji","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"4764_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united states. JAMA Oncol 3:1335. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"4764_CR2","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","volume":"23","author":"BE White","year":"2022","unstructured":"White BE, Rous B, Chandrakumaran K, et al (2022) Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: A retrospective, population-based study. The Lancet Regional Health - Europe 23:100510. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100510","journal-title":"The Lancet Regional Health - Europe"},{"key":"4764_CR3","doi-asserted-by":"publisher","first-page":"101836","DOI":"10.1016\/j.beem.2023.101836","volume":"37","author":"M Passhak","year":"2023","unstructured":"Passhak M, McNamara MG, Hubner RA, et al (2023) Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence? Best Practice & Research Clinical Endocrinology & Metabolism 37:101836. https:\/\/doi.org\/10.1016\/j.beem.2023.101836","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"key":"4764_CR4","doi-asserted-by":"publisher","first-page":"R519","DOI":"10.1530\/ERC-19-0175","volume":"26","author":"CP Pipinikas","year":"2019","unstructured":"Pipinikas CP, Berner AM, Sposito T, Thirlwell C (2019) The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours. Endocr Relat Cancer 26:R519\u2013R544. https:\/\/doi.org\/10.1530\/ERC-19-0175","journal-title":"Endocr Relat Cancer"},{"key":"4764_CR5","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1210\/jc.2003-031575","volume":"89","author":"AO Vortmeyer","year":"2004","unstructured":"Vortmeyer AO, Huang S, Lubensky I, Zhuang Z (2004) Non-islet origin of pancreatic islet cell tumors. The Journal of Clinical Endocrinology & Metabolism 89:1934\u20131938. https:\/\/doi.org\/10.1210\/jc.2003-031575","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"4764_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.21037\/jgo.2020.03.09","volume":"11","author":"JL Geurts","year":"2020","unstructured":"Geurts JL (2020) Inherited syndromes involving pancreatic neuroendocrine tumors. J Gastrointest Oncol 11:559\u2013566. https:\/\/doi.org\/10.21037\/jgo.2020.03.09","journal-title":"J Gastrointest Oncol"},{"key":"4764_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, et al (2022) Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol 33:115\u2013154. https:\/\/doi.org\/10.1007\/s12022-022-09708-2","journal-title":"Endocr Pathol"},{"key":"4764_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182\u2013188. https:\/\/doi.org\/10.1111\/his.13975","journal-title":"Histopathology"},{"key":"4764_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5732\/cjc.012.10295","volume":"32","author":"C Ro","year":"2013","unstructured":"Ro C, Chai W, Yu VE, Yu R (2013) Pancreatic neuroendocrine tumors: Biology, diagnosis,and treatment. Chin J Cancer 32:312\u2013324. https:\/\/doi.org\/10.5732\/cjc.012.10295","journal-title":"Chin J Cancer"},{"key":"4764_CR10","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/annonc\/mdn351","volume":"19","author":"TR Halfdanarson","year":"2008","unstructured":"Halfdanarson TR, Rabe KG, Rubin J, Petersen GM (2008) Pancreatic neuroendocrine tumors (PNETs): Incidence, prognosis and recent trend toward improved survival. Annals of Oncology 19:1727\u20131733. https:\/\/doi.org\/10.1093\/annonc\/mdn351","journal-title":"Annals of Oncology"},{"key":"4764_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","volume":"19","author":"B Oronsky","year":"2017","unstructured":"Oronsky B, Ma PC, Morgensztern D, Carter CA (2017) Nothing but NET: A review of neuroendocrine tumors and carcinomas. Neoplasia 19:991\u20131002. https:\/\/doi.org\/10.1016\/j.neo.2017.09.002","journal-title":"Neoplasia"},{"key":"4764_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Australian Pancreatic Cancer Genome Initiative, Scarpa A, Chang DK, et al (2017) Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543:65\u201371. https:\/\/doi.org\/10.1038\/nature21063","journal-title":"Nature"},{"key":"4764_CR13","doi-asserted-by":"publisher","unstructured":"Jiao Y, Shi C, Edil BH, et al (2011) DAXX \/ ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331:1199\u20131203. https:\/\/doi.org\/10.1126\/science.1200609","DOI":"10.1126\/science.1200609"},{"key":"4764_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2214\/AJR.19.22542","volume":"215","author":"A Davila","year":"2020","unstructured":"Davila A, Menias CO, Alhalabi K, et al (2020) Multiple endocrine neoplasia: Spectrum of abdominal manifestations. American Journal of Roentgenology 215:885\u2013895. https:\/\/doi.org\/10.2214\/AJR.19.22542","journal-title":"American Journal of Roentgenology"},{"key":"4764_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/332085a0","volume":"332","author":"C Larsson","year":"1988","unstructured":"Larsson C, Skogseid B, \u00d6berg K, et al (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85\u201387. https:\/\/doi.org\/10.1038\/332085a0","journal-title":"Nature"},{"key":"4764_CR16","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ng.2821","volume":"45","author":"JM Francis","year":"2013","unstructured":"Francis JM, Kiezun A, Ramos AH, et al (2013) Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet 45:1483\u20131486. https:\/\/doi.org\/10.1038\/ng.2821","journal-title":"Nat Genet"},{"key":"4764_CR17","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"4764_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ando.2023.11.005","volume":"85","author":"N Sahakian","year":"2024","unstructured":"Sahakian N, Castinetti F, Romanet P, et al (2024) Updates on the genetics of multiple endocrine neoplasia. Annales d\u2019Endocrinologie 85:127\u2013135. https:\/\/doi.org\/10.1016\/j.ando.2023.11.005","journal-title":"Annales d\u2019Endocrinologie"},{"key":"4764_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ando.2006.11.003","volume":"68","author":"P Goudet","year":"2007","unstructured":"Goudet P, Bonithon C, Costa A, et al (2007) Observatoire francophone des n\u00e9oplasies endocriniennes multiples de type 1. Un outil du groupe d\u2019\u00e9tude des tumeurs endocrines (GTE). Annales d\u2019Endocrinologie 68:154\u2013159. https:\/\/doi.org\/10.1016\/j.ando.2006.11.003","journal-title":"Annales d\u2019Endocrinologie"},{"key":"4764_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","volume":"17","author":"A Al-Salameh","year":"2021","unstructured":"Al-Salameh A, Cadiot G, Calender A, et al (2021) Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol 17:207\u2013224. https:\/\/doi.org\/10.1038\/s41574-021-00468-3","journal-title":"Nat Rev Endocrinol"},{"key":"4764_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2214\/AJR.11.8037","volume":"200","author":"A Gallotti","year":"2013","unstructured":"Gallotti A, Johnston RP, Bonaffini PA, et al (2013) Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy. American Journal of Roentgenology 200:355\u2013362. https:\/\/doi.org\/10.2214\/AJR.11.8037","journal-title":"American Journal of Roentgenology"},{"key":"4764_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","volume":"58","author":"F Giusti","year":"2017","unstructured":"Giusti F, Cianferotti L, Boaretto F, et al (2017) Multiple endocrine neoplasia syndrome type 1: Institution, management, and data analysis of a nationwide multicenter patient database. Endocrine 58:349\u2013359. https:\/\/doi.org\/10.1007\/s12020-017-1234-4","journal-title":"Endocrine"},{"key":"4764_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000431323","volume":"84","author":"I Ben-Skowronek","year":"2015","unstructured":"Ben-Skowronek I, Kozaczuk S (2015) Von hippel-lindau syndrome. Horm Res Paediatr 84:145\u2013152. https:\/\/doi.org\/10.1159\/000431323","journal-title":"Horm Res Paediatr"},{"key":"4764_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1148\/rg.2018170156","volume":"38","author":"D Ganeshan","year":"2018","unstructured":"Ganeshan D, Menias CO, Pickhardt PJ, et al (2018) Tumors in von hippel\u2013lindau syndrome: From head to toe\u2014comprehensive state-of-the-art review. RadioGraphics 38:849\u2013866. https:\/\/doi.org\/10.1148\/rg.2018170156","journal-title":"RadioGraphics"},{"key":"4764_CR25","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, et al (2003) von hippel-lindau disease. The Lancet 361:2059\u20132067. https:\/\/doi.org\/10.1016\/S0140-6736(03)13643-4","journal-title":"The Lancet"},{"key":"4764_CR26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(04)15957-6","volume":"363","author":"S Richard","year":"2004","unstructured":"Richard S, Graff J, Lindau J, Resche F (2004) Von hippel-lindau disease. The Lancet 363:1231\u20131234. https:\/\/doi.org\/10.1016\/S0140-6736(04)15957-6","journal-title":"The Lancet"},{"key":"4764_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrclinonc.2016.37","volume":"13","author":"XM Keutgen","year":"2016","unstructured":"Keutgen XM, Hammel P, Choyke PL, et al (2016) Evaluation and management of pancreatic lesions in patients with von hippel\u2013lindau disease. Nat Rev Clin Oncol 13:537\u2013549. https:\/\/doi.org\/10.1038\/nrclinonc.2016.37","journal-title":"Nat Rev Clin Oncol"},{"key":"4764_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jamcollsurg.2013.10.025","volume":"218","author":"AB Weisbrod","year":"2014","unstructured":"Weisbrod AB, Kitano M, Thomas F, et al (2014) Assessment of tumor growth in pancreatic neuroendocrine tumors in von hippel lindau syndrome. Journal of the American College of Surgeons 218:163\u2013169. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2013.10.025","journal-title":"Journal of the American College of Surgeons"},{"key":"4764_CR29","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1067\/msy.2000.110239","volume":"128","author":"SK Libutti","year":"2000","unstructured":"Libutti SK, Choyke PL, Alexander HR, et al (2000) Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von hippel-lindau disease. Surgery 128:1022\u20131028. https:\/\/doi.org\/10.1067\/msy.2000.110239","journal-title":"Surgery"},{"key":"4764_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(09)70033-6","volume":"10","author":"H Brems","year":"2009","unstructured":"Brems H, Beert E, De Ravel T, Legius E (2009) Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. The Lancet Oncology 10:508\u2013515. https:\/\/doi.org\/10.1016\/S1470-2045(09)70033-6","journal-title":"The Lancet Oncology"},{"key":"4764_CR31","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and legius syndrome: An international consensus recommendation. Genetics in Medicine 23:1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genetics in Medicine"},{"key":"4764_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1055\/s-0035-1553505","volume":"187","author":"J Salamon","year":"2015","unstructured":"Salamon J, Mautner VF, Adam G, Derlin T (2015) Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors. Rofo 187:1084\u20131092. https:\/\/doi.org\/10.1055\/s-0035-1553505","journal-title":"Rofo"},{"key":"4764_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00428-007-0450-3","volume":"451","author":"M Anlauf","year":"2007","unstructured":"Anlauf M, Garbrecht N, Bauersfeld J, et al (2007) Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch 451:29\u201338. https:\/\/doi.org\/10.1007\/s00428-007-0450-3","journal-title":"Virchows Arch"},{"key":"4764_CR34","doi-asserted-by":"publisher","unstructured":"Northrup H, Krueger DA, Northrup H, et al (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:243\u2013254. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.001","DOI":"10.1016\/j.pediatrneurol.2013.08.001"},{"key":"4764_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/abd1806-4841.20186972","volume":"93","author":"LKL Portocarrero","year":"2018","unstructured":"Portocarrero LKL, Quental KN, Samorano LP, et al (2018) Tuberous sclerosis complex: Review based on new diagnostic criteria. An Bras Dermatol 93:323\u2013331. https:\/\/doi.org\/10.1590\/abd1806-4841.20186972","journal-title":"An Bras Dermatol"},{"key":"4764_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00247-016-3701-0","volume":"47","author":"G Koc","year":"2017","unstructured":"Koc G, Sugimoto S, Kuperman R, et al (2017) Pancreatic tumors in children and young adults with tuberous sclerosis complex. Pediatr Radiol 47:39\u201345. https:\/\/doi.org\/10.1007\/s00247-016-3701-0","journal-title":"Pediatr Radiol"},{"key":"4764_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1399-0004.2011.01805.x","volume":"82","author":"A Larson","year":"2012","unstructured":"Larson A, Hedgire S, Deshpande V, et al (2012) Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex. Clinical Genetics 82:558\u2013563. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01805.x","journal-title":"Clinical Genetics"},{"key":"4764_CR38","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s00259-019-04455-9","volume":"46","author":"A Toriihara","year":"2019","unstructured":"Toriihara A, Baratto L, Nobashi T, et al (2019) Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET\/CT in patients with well-differentiated neuroendocrine tumors. Eur J Nucl Med Mol Imaging 46:2244\u20132251. https:\/\/doi.org\/10.1007\/s00259-019-04455-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4764_CR39","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.3390\/ijerph18178895","volume":"18","author":"G Chiti","year":"2021","unstructured":"Chiti G, Grazzini G, Cozzi D, et al (2021) Imaging of Pancreatic Neuroendocrine Neoplasms. IJERPH 18:8895. https:\/\/doi.org\/10.3390\/ijerph18178895","journal-title":"IJERPH"},{"key":"4764_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/ejendo\/lvad035","volume":"188","author":"I Kostiainen","year":"2023","unstructured":"Kostiainen I, Majala S, Schildt J, et al (2023) Pancreatic imaging in MEN1\u2014comparison of conventional and somatostatin receptor positron emission tomography\/computed tomography imaging in real-life setting. European Journal of Endocrinology 188:421\u2013429. https:\/\/doi.org\/10.1093\/ejendo\/lvad035","journal-title":"European Journal of Endocrinology"},{"key":"4764_CR41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jamcollsurg.2015.04.005","volume":"221","author":"SM Sadowski","year":"2015","unstructured":"Sadowski SM, Millo C, Cottle-Delisle C, et al (2015) Results of 68Gallium-DOTATATE PET\/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1. Journal of the American College of Surgeons 221:509\u2013517. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.04.005","journal-title":"Journal of the American College of Surgeons"},{"key":"4764_CR42","doi-asserted-by":"publisher","first-page":"e2056","DOI":"10.1210\/clinem\/dgab891","volume":"107","author":"C Mennetrey","year":"2022","unstructured":"Mennetrey C, Le Bras M, Bando-Delaunay A, et al (2022) Value of Somatostatin Receptor PET\/CT in Patients With MEN1 at Various Stages of Their Disease. The Journal of Clinical Endocrinology & Metabolism 107:e2056\u2013e2064. https:\/\/doi.org\/10.1210\/clinem\/dgab891","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"4764_CR43","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12149-012-0634-z","volume":"26","author":"V Froeling","year":"2012","unstructured":"Froeling V, Elgeti F, Maurer MH, et al (2012) Impact of Ga-68 DOTATOC PET\/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia. Ann Nucl Med 26:738\u2013743. https:\/\/doi.org\/10.1007\/s12149-012-0634-z","journal-title":"Ann Nucl Med"},{"key":"4764_CR44","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.acra.2023.10.040","volume":"31","author":"H-Y Chen","year":"2024","unstructured":"Chen H-Y, Pan Y, Chen J-Y, et al (2024) Machine Learning Methods Based on CT Features Differentiate G1\/G2 From G3 Pancreatic Neuroendocrine Tumors. Acad Radiol 31:1898\u20131905. https:\/\/doi.org\/10.1016\/j.acra.2023.10.040","journal-title":"Acad Radiol"},{"key":"4764_CR45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/1078-0432.CCR-18-1305","volume":"25","author":"W Liang","year":"2019","unstructured":"Liang W, Yang P, Huang R, et al (2019) A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clinical Cancer Research 25:584\u2013594. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1305","journal-title":"Clinical Cancer Research"},{"key":"4764_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.rcl.2015.12.003","volume":"54","author":"A Krishnan","year":"2016","unstructured":"Krishnan A, Kaza RK, Vummidi DR (2016) Cross-sectional Imaging Review of Tuberous Sclerosis. Radiol Clin North Am 54:423\u2013440. https:\/\/doi.org\/10.1016\/j.rcl.2015.12.003","journal-title":"Radiol Clin North Am"},{"key":"4764_CR47","doi-asserted-by":"publisher","first-page":"e235129","DOI":"10.1136\/bcr-2020-235129","volume":"13","author":"N Vongsumran","year":"2020","unstructured":"Vongsumran N, Kongkarnka S, Watanawittawas P, Manosroi W (2020) Pheochromocytoma and gastrointestinal stromal tumours in an adult neurofibromatosis type 1 patient: a rare co-occurrence. BMJ Case Rep 13:e235129. https:\/\/doi.org\/10.1136\/bcr-2020-235129","journal-title":"BMJ Case Rep"},{"key":"4764_CR48","doi-asserted-by":"publisher","first-page":"e4154","DOI":"10.1210\/clinem\/dgac454","volume":"107","author":"A Lagarde","year":"2022","unstructured":"Lagarde A, Le Collen L, Boulagnon C, et al (2022) Early Detection of Relapse by ctDNA Sequencing in a Patient with Metastatic Thymic Tumor and MEN1 Mosaicism. The Journal of Clinical Endocrinology & Metabolism 107:e4154\u2013e4158. https:\/\/doi.org\/10.1210\/clinem\/dgac454","journal-title":"The Journal of Clinical Endocrinology & Metabolism"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04764-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T18:03:48Z","timestamp":1750442628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4764"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04764-0","relation":{},"ISSN":["2366-0058"],"issn-type":[{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}